Arafarma Group, S.A.
7
1
1
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
29%
2 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Impact of Food Supplementation on Quality of Life in Patients With Endometriosis and Pelvic Pain.
Role: lead
Impact of a Food Supplement on Musculoskeletal Pain in Women With Breast Cancer Treated With Aromatase Inhibitors.
Role: lead
Effects of a Food Supplement in the Prevention of Urinary Tract Infections in Kidney Transplant Patients.
Role: lead
Study of the Administration of a Food Supplement in Patients With Lithiasis Treated With Extracorporeal Shock Wave Lithotripsy.
Role: lead
Study of the Symptomatic Improvement in Patients With Fibromyalgia by Means of a Food Supplement
Role: lead
Effects of a Food Supplement on Quality of Life in Patients With Chronic Obstructive Pulmonary Disease.
Role: lead
Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.
Role: lead
All 7 trials loaded